Aristides Capital LLC Bio N Tech Se Transaction History
Aristides Capital LLC
- $219 Million
- Q3 2024
A detailed history of Aristides Capital LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Aristides Capital LLC holds 11,900 shares of BNTX stock, worth $1.37 Million. This represents 0.65% of its overall portfolio holdings.
Number of Shares
11,900
Previous 11,900
-0.0%
Holding current value
$1.37 Million
Previous $956,000
47.8%
% of portfolio
0.65%
Previous 0.44%
Shares
2 transactions
Others Institutions Holding BNTX
# of Institutions
357Shares Held
38.4MCall Options Held
2.45MPut Options Held
2.29M-
Baillie Gifford & CO8.31MShares$957 Million0.75% of portfolio
-
Primecap Management CO Pasadena, CA4.52MShares$520 Million0.4% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.36MShares$502 Million2.05% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$218 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$208 Million0.88% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $28B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...